AI & ChatGPT searches , social queries for EPTINEZUMAB

Search references for EPTINEZUMAB. Phrases containing EPTINEZUMAB

See searches and references containing EPTINEZUMAB!

AI searches containing EPTINEZUMAB

EPTINEZUMAB

  • Eptinezumab

    • Monoclonal antibody

    Eptinezumab, sold under the brand name Vyepti, is a medication used for the preventive treatment of migraine in adults. It is a monoclonal antibody that

    Eptinezumab

    Eptinezumab

  • Calcitonin gene-related peptide receptor antagonist

    • Class of drugs

    SB-268262 Erenumab (AMG-334) is approved for prevention of migraine. Eptinezumab (ALD403) is approved for prevention of migraine. Fremanezumab (TEV-48125)

    Calcitonin gene-related peptide receptor antagonist

    Calcitonin_gene-related_peptide_receptor_antagonist

  • Monoclonal antibody

    • Antibodies from clones of the same blood cell

    Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab

    Monoclonal antibody

    Monoclonal antibody

    Monoclonal_antibody

  • Meloxicam/rizatriptan

    • Combination medication

    Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant

    Meloxicam/rizatriptan

    Meloxicam/rizatriptan

  • ATC code N02

    • Pharmaceutical drug classification

    N02CD02 Galcanezumab N02CD03 Fremanezumab N02CD04 Ubrogepant N02CD05 Eptinezumab N02CD06 Rimegepant N02CD07 Atogepant N02CD08 Zavegepant N02CX01 Pizotifen

    ATC code N02

    ATC_code_N02

  • Migraine

    • Disorder resulting in recurrent moderate–severe headaches

    Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant

    Migraine

    Migraine

    Migraine

  • Galcanezumab

    • Monoclonal antibody

    Spreitzer H (3 July 2017). "Neue Wirkstoffe: Galcanezumab, Fremanezumab und Eptinezumab". Österreichische Apothekerzeitung (in German) (14/2017). "Drug Approval

    Galcanezumab

    Galcanezumab

    Galcanezumab

  • Prevention of migraine attacks

    • Methods to reduce the frequency and severity of migraine attacks

    Medications in the anti-calcitonin gene-related peptide, including eptinezumab, erenumab, fremanezumab, and galcanezumab, appear to decrease the frequency

    Prevention of migraine attacks

    Prevention_of_migraine_attacks

  • Rimegepant

    • Medication for acute migraine in adults

    Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant

    Rimegepant

    Rimegepant

    Rimegepant

  • Clonidine

    • Alpha-adrenergic agonist

    Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant

    Clonidine

    Clonidine

    Clonidine

  • Romosozumab

    • Pharmaceutical drug

    Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab

    Romosozumab

    Romosozumab

  • List of investigational headache and migraine drugs

    • Investigational antimigraine drugs

    acetylcholine release inhibitor and neuromuscular blocking agent – migraine [2] Eptinezumab (ALD-403; Lu-AG09221; Vyepti) – monoclonal antibody against calcitonin

    List of investigational headache and migraine drugs

    List_of_investigational_headache_and_migraine_drugs

  • Concizumab

    • Medication

    Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab

    Concizumab

    Concizumab

  • Donanemab

    • Monoclonal antibody against amyloid beta

    Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab

    Donanemab

    Donanemab

  • Lecanemab

    • Monoclonal antibody against amyloid beta

    Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab

    Lecanemab

    Lecanemab

  • Anti-amyloid antibodies

    • Drug class

    Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab

    Anti-amyloid antibodies

    Anti-amyloid_antibodies

  • Evolocumab

    • Pharmaceutical drug

    Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab

    Evolocumab

    Evolocumab

  • Calcitonin gene-related peptide

    • Peptide hormone in animals

    an oral medication manufactured by AbbVie. Also approved that month, eptinezumab (Vyepti), is an intravenous migraine prophylactic medication manufactured

    Calcitonin gene-related peptide

    Calcitonin gene-related peptide

    Calcitonin_gene-related_peptide

  • Zavegepant

    • Medication for treatment of migraine

    Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant

    Zavegepant

    Zavegepant

    Zavegepant

  • Bedinvetmab

    • Monoclonal antibody

    Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab

    Bedinvetmab

    Bedinvetmab

    Bedinvetmab

  • Prasinezumab

    • Experimental monoclonal antibody

    Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab

    Prasinezumab

    Prasinezumab

  • Devextinetug

    • Pharmaceutical compound

    Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab

    Devextinetug

    Devextinetug

  • Management of chronic headaches

    • Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant

    Management of chronic headaches

    Management of chronic headaches

    Management_of_chronic_headaches

  • Opicinumab

    • Monoclonal antibody

    Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab

    Opicinumab

    Opicinumab

  • Humanized antibody

    • Antibodies from non-human species made nearly identical to human ones

    Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab

    Humanized antibody

    Humanized_antibody

  • Signaling peptide receptor

    • Cell surface receptors

    MK-3207 Olcegepant Rimegepant SB-268262 Telcagepant Ubrogepant Antibodies Eptinezumab Erenumab Fremanezumab Galcanezumab Agonists Cholecystokinin Antagonists

    Signaling peptide receptor

    Signaling_peptide_receptor

  • Fremanezumab

    • Pharmaceutical biological monoclonal antibody

    Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant

    Fremanezumab

    Fremanezumab

  • Anti-α-synuclein drug

    • Drugs that inhibit α-synuclein

    Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab

    Anti-α-synuclein drug

    Anti-α-synuclein_drug

  • Tadocizumab

    • Monoclonal antibody

    Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab

    Tadocizumab

    Tadocizumab

  • Bimagrumab

    • Chemical compound

    Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab

    Bimagrumab

    Bimagrumab

  • Relfovetmab

    • Veterinary medication

    Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab

    Relfovetmab

    Relfovetmab

  • Atogepant

    • Chemical compound

    Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant

    Atogepant

    Atogepant

    Atogepant

  • Ubrogepant

    • Medication for migraine headache acute treatment

    Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant

    Ubrogepant

    Ubrogepant

    Ubrogepant

  • Erenumab

    • Chemical compound

    Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant

    Erenumab

    Erenumab

    Erenumab

  • Alirocumab

    • Pharmaceutical drug

    Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab

    Alirocumab

    Alirocumab

  • Aducanumab

    • Monoclonal antibody against amyloid beta

    Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab

    Aducanumab

    Aducanumab

  • Bevacizumab

    • Medication

    Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab

    Bevacizumab

    Bevacizumab

  • Izenivetmab

    • Veterinary medication

    Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab

    Izenivetmab

    Izenivetmab

  • Topiramate

    • Medication used to treat epilepsy and migraine

    Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant

    Topiramate

    Topiramate

    Topiramate

  • Ditan

    • Drug class

    Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant

    Ditan

    Ditan

    Ditan

  • Management of migraine

    • Management of neurological disorder

    Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant

    Management of migraine

    Management_of_migraine

  • Emicizumab

    • Monoclonal antibody

    Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab

    Emicizumab

    Emicizumab

    Emicizumab

  • List of therapeutic monoclonal antibodies

    • from the original on 15 July 2020. Retrieved 23 January 2020. "Vyepti- eptinezumab-jjmr injection". DailyMed. Archived from the original on 28 September

    List of therapeutic monoclonal antibodies

    List of therapeutic monoclonal antibodies

    List_of_therapeutic_monoclonal_antibodies

  • Sumatriptan

    • Medication used for migraines & cluster headaches

    Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant

    Sumatriptan

    Sumatriptan

    Sumatriptan

  • Amidrine

    • Combination drug

    Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant

    Amidrine

    Amidrine

  • Denosumab

    • Human monoclonal antibody

    Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab

    Denosumab

    Denosumab

  • Olcegepant

    • Chemical compound

    Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant

    Olcegepant

    Olcegepant

    Olcegepant

  • Marstacimab

    • Medication

    Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab

    Marstacimab

    Marstacimab

  • Tanezumab

    • Chemical compound

    Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab

    Tanezumab

    Tanezumab

  • Ascrinvacumab

    • Chemical compound

    Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab

    Ascrinvacumab

    Ascrinvacumab

  • Abciximab

    • Pharmaceutical compound

    Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab

    Abciximab

    Abciximab

    Abciximab

  • Bapineuzumab

    • Chemical compound

    Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab

    Bapineuzumab

    Bapineuzumab

  • Naratriptan

    • Chemical compound

    Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant

    Naratriptan

    Naratriptan

    Naratriptan

  • Idarucizumab

    • Medication

    Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab

    Idarucizumab

    Idarucizumab

  • Ergotamine

    • Chemical compound in the ergot family of alkaloids

    Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant

    Ergotamine

    Ergotamine

    Ergotamine

  • Dihydroergocryptine

    • Chemical compound

    Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant

    Dihydroergocryptine

    Dihydroergocryptine

    Dihydroergocryptine

  • Rizatriptan

    • Medication used for the treatment of migraine headaches

    Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant

    Rizatriptan

    Rizatriptan

    Rizatriptan

  • Avitriptan

    • Chemical compound

    Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant

    Avitriptan

    Avitriptan

    Avitriptan

  • Burosumab

    • Monoclonal antibody designed to treat X-linked hypophosphatemia

    Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab

    Burosumab

    Burosumab

  • Triptan

    • Class of pharmaceutical drugs

    Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant

    Triptan

    Triptan

    Triptan

  • Trevogrumab

    • Monoclonal antibody

    Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab

    Trevogrumab

    Trevogrumab

  • Gantenerumab

    • Monoclonal antibody protein

    Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab

    Gantenerumab

    Gantenerumab

    Gantenerumab

  • Caplacizumab

    • Chemical compound

    Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab

    Caplacizumab

    Caplacizumab

  • Ergotamine/caffeine

    • Pharmaceutical product

    Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant

    Ergotamine/caffeine

    Ergotamine/caffeine

  • Crenezumab

    • Antibody tested against Alzheimer's

    Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab

    Crenezumab

    Crenezumab

  • List of signaling peptide/protein receptor modulators

    • MK-3207 Olcegepant Rimegepant SB-268262 Telcagepant Ubrogepant Antibodies: Eptinezumab Erenumab Fremanezumab Galcanezumab Agonists: Cholecystokinin Antagonists:

    List of signaling peptide/protein receptor modulators

    List_of_signaling_peptide/protein_receptor_modulators

  • Solanezumab

    • Monoclonal antibody medication

    Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab

    Solanezumab

    Solanezumab

  • Telcagepant

    • Chemical compound

    Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant

    Telcagepant

    Telcagepant

    Telcagepant

  • Semorinemab

    • Anti-tau monoclonal antibody

    Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab

    Semorinemab

    Semorinemab

  • Methysergide

    • Chemical compound

    Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant

    Methysergide

    Methysergide

    Methysergide

  • Antimigraine drug

    • Medication intended to reduce the effects or intensity of migraine headache

    Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant

    Antimigraine drug

    Antimigraine drug

    Antimigraine_drug

  • Pizotifen

    • Drug used to reduce frequency of headaches

    Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant

    Pizotifen

    Pizotifen

    Pizotifen

  • Eletriptan

    • Chemical compound

    Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant

    Eletriptan

    Eletriptan

    Eletriptan

  • Methylergometrine

    • Chemical compound

    Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant

    Methylergometrine

    Methylergometrine

    Methylergometrine

  • Ozanezumab

    • Monoclonal antibody

    Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab

    Ozanezumab

    Ozanezumab

  • Ranibizumab

    • Pharmaceutical drug

    Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab

    Ranibizumab

    Ranibizumab

  • Zolmitriptan

    • Medication used in treatment of migraines

    Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant

    Zolmitriptan

    Zolmitriptan

    Zolmitriptan

  • Alpiropride

    • Antimigraine agent

    Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant

    Alpiropride

    Alpiropride

    Alpiropride

  • Inclacumab

    • Monoclonal antibody

    Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab

    Inclacumab

    Inclacumab

  • Dihydroergotamine

    • Chemical used to treat migraines

    Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant

    Dihydroergotamine

    Dihydroergotamine

    Dihydroergotamine

  • Lisuride

    • Chemical compound

    Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant

    Lisuride

    Lisuride

    Lisuride

  • Lomerizine

    • Chemical compound

    Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant

    Lomerizine

    Lomerizine

    Lomerizine

  • Bococizumab

    • Chemical compound

    Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab

    Bococizumab

    Bococizumab

  • Blosozumab

    • Chemical compound

    Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab

    Blosozumab

    Blosozumab

  • Stamulumab

    • Monoclonal antibody

    Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab

    Stamulumab

    Stamulumab

  • Bentracimab

    • Medication

    Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab

    Bentracimab

    Bentracimab

  • Abelacimab

    • Monoclonal antibody

    Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab

    Abelacimab

    Abelacimab

  • Faricimab

    • Medication for macular degeneration

    Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab

    Faricimab

    Faricimab

    Faricimab

  • Brolucizumab

    • Pharmaceutical drug

    Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab

    Brolucizumab

    Brolucizumab

  • Frovatriptan

    • Chemical compound

    Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant

    Frovatriptan

    Frovatriptan

    Frovatriptan

  • Rinucumab

    • Monoclonal antibody

    Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab

    Rinucumab

    Rinucumab

  • Fasinumab

    • Monoclonal antibody

    Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab

    Fasinumab

    Fasinumab

  • Enoticumab

    • Monoclonal antibody

    Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab

    Enoticumab

    Enoticumab

  • Cinpanemab

    • Experimental monoclonal antibody

    Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab

    Cinpanemab

    Cinpanemab

  • Ramucirumab

    • Pharmaceutical drug

    Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab

    Ramucirumab

    Ramucirumab

  • BOL-148

    • Chemical compound

    Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant

    BOL-148

    BOL-148

    BOL-148

  • Lasmiditan

    • Chemical compound

    Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant

    Lasmiditan

    Lasmiditan

    Lasmiditan

  • Indium (111In) imciromab

    • Pharmaceutical compound

    Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab

    Indium (111In) imciromab

    Indium_(111In)_imciromab

  • Almotriptan

    • Chemical compound

    Carbamazepine Oxcarbazepine Topiramate Valproate Anti-CGRP/CGRP-R mAbs Eptinezumab Erenumab Fremanezumab Galcanezumab CGRP-R antagonists Atogepant Rimegepant

    Almotriptan

    Almotriptan

    Almotriptan

  • Refanezumab

    • Monoclonal antibody

    Fasinumab† Fulranumab Opicinumab Humanized Bapineuzumab† Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab

    Refanezumab

    Refanezumab

AI & ChatGPT searchs for online references containing EPTINEZUMAB

EPTINEZUMAB

AI search references containing EPTINEZUMAB

EPTINEZUMAB

AI search queries for Facebook and twitter posts, hashtags with EPTINEZUMAB

EPTINEZUMAB

Follow users with usernames @EPTINEZUMAB or posting hashtags containing #EPTINEZUMAB

EPTINEZUMAB

Online names & meanings

AI search & ChatGPT queries for Facebook and twitter users, user names, hashtags with EPTINEZUMAB

EPTINEZUMAB

Top AI & ChatGPT search, Social media, medium, facebook & news articles containing EPTINEZUMAB

EPTINEZUMAB

AI searchs for Acronyms & meanings containing EPTINEZUMAB

EPTINEZUMAB

AI searches, Indeed job searches and job offers containing EPTINEZUMAB

Other words and meanings similar to

EPTINEZUMAB

AI search in online dictionary sources & meanings containing EPTINEZUMAB

EPTINEZUMAB